Skip to main content
. 2015 Aug 27;113(6):952–962. doi: 10.1038/bjc.2015.297

Table 1. Result from two-way ANOVA of analysed APM components.

APM component GCLs Experimental time points Interaction
ERAP1 1.33*10−15 4.94*10−2 5.70*10−2
LMP2 2.83*10−11 5.31*10−8 4.00*10−4
ERp57 2.13*10−10 3.72*10−6 6.61*10−4
Tapasin 2.68*10−10 2.17*10−7 2.84*10−2
β2m 8.74*10−10 8.10*10−6 3.00*10−1
LMP7 2.18*10−9 7.90*10−7 1.69*10−5
HLA-I HC 3.27*10−8 2.36*10−5 5.23*10−3
TAP1 5.01*10−7 1.77*10−3 2.79*10−4
ERAP2 4.66*10−6 4.66*10−1 5.92*10−5
TAP2 3.21*10−5 2.42*10−3 2.65*10−2
Calnexin 1.24*10−3 1.51*10−3 5.49*10−3
Calreticulin 2.65*10−3 1.13*10−3 5.14*10−1
β-COPI 1.94*10−2 3.27*10−2 1.03*10−2
BAP31 5.92*10−1 2.76*10−3 9.33*10−1

Abbreviations: ANOVA=analysis of variance; APM=antigen-processing machinery; β2m2-microglobulin; GCL=glioma cell line; HC=heavy chain.

All the reported numbers are P-values.